Rare diseases
Investigational molecules
Locations
Back to Slovakia10 clinical trials in Liptovsky Mikulas, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on Seltorexant for Adults and Elderly with Major Depressive Disorder and Insomnia Symptoms
SlovakiaLong‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder
SlovakiaA study of azetukalner compared to placebo for adults with moderate-to-severe major depressive disorder
SlovakiaStudy of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks
SlovakiaStudy of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients
SlovakiaStudy on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments
SlovakiaStudy on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety
SlovakiaStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
SlovakiaStudy on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
SlovakiaStudy on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on migraine prevention and treatment, with multiple studies evaluating novel therapeutic approaches for both acute attacks and long-term prevention.
Advanced clinical investigations are exploring both immediate relief and prophylactic solutions for migraine sufferers.
Comprehensive studies addressing Major Depressive Disorder (MDD), particularly focusing on combination therapies with existing antidepressants for enhanced treatment outcomes.
Research aims to improve treatment responses in patients who haven't achieved adequate results with standard therapies.
Groundbreaking research in stroke prevention and management, specifically targeting post-ischemic stroke care and high-risk transient ischemic attack patients.
Studies focus on innovative therapeutic agents to prevent recurrent strokes and manage chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
